Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
PINNELL et al v. TEVA PHARMACEUTICALS USA, INC. et al
Case Number:
2:19-cv-05738
Court:
Nature of Suit:
Multi Party Litigation:
Class Action
Judge:
Firms
Companies
Sectors & Industries:
-
November 19, 2020
Teva Inks $2.55M Deal To Settle 401(k) Fee Suit
Teva Pharmaceuticals USA Inc. has agreed to pay nearly $2.6 million to wrap up a proposed ERISA class action accusing it of including unnecessarily costly investments in a 401(k) plan that also allegedly charged too much for administrative fees, according to documents filed in Pennsylvania federal court.
-
October 16, 2020
Teva, Workers Reach Deal To Settle 401(k) Fee Suit
A Pennsylvania federal judge gave Teva Pharmaceuticals the go-ahead Friday to draw up settlement paperwork in a deal with roughly 10,000 current and former workers in a lawsuit over the drugmaker's 401(k) plan fees and investments.
-
March 31, 2020
Teva Can't Nix ERISA Suit Over Excessive Fee Allegations
A Pennsylvania federal judge on Tuesday denied a bid by Teva Pharmaceuticals USA Inc. to toss a proposed class action accusing the drugmaker of saddling its 401(k) plan participants with excessive fees, saying the U.S. Supreme Court's denial this week of a plan's petition for certiorari provided "guideposts" on the ruling.
-
March 04, 2020
Teva Wants 'Scattershot' 401(k) Fee Suit Scrapped
Teva Pharmaceuticals USA Inc. has urged a Pennsylvania federal judge to toss a "scattershot" proposed class action accusing the drugmaker of saddling participants in its 401(k) plan with excessive fees, arguing it wasn't obligated to choose the cheapest possible investment options.
-
December 09, 2019
Workers Say Teva 401(k) Mismanagement Cost Them Millions
Teva Pharmaceuticals USA Inc. has been hit with a proposed class action accusing the company of costing participants in its 401(k) retirement plan millions of dollars by keeping high-cost investment choices in the plan and not properly reviewing its investment lineup.